Meeting
2023 ASCO Annual Meeting
Pan-cancer analysis of natural killer (NK) cell infiltration in human malignancies: Molecular features and clinical implications.
Authors
Nick Zorko
University of Minnesota, Minneapolis, MN
Nick Zorko , Justin Hwang , John R Lozada , Hilary Seifert , Andrew Elliott , Milan Radovich , George W. Sledge Jr., Martin Felices , Elisabeth I. Heath , Dave S. B. Hoon , Wafik S. El-Deiry , Jeffrey Miller , Emmanuel S. Antonarakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Immunobiology
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2563)
DOI
10.1200/JCO.2023.41.16_suppl.2563
Abstract #
2563
Poster Bd #
405
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Effect of combined treatment with sipuleucel-T and IL-15 on tumor control, tumor-infiltrating immune effectors, and key mediators of immunoresistance in a preclinical prostate cancer model.
First Author: Russell Kent Pachynski
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2023 ASCO Annual Meeting
Comprehensive characterization of androgen receptor expression in breast cancer.
First Author: Priya Jayachandran
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita